Cidan Capsules
Function and Efficacy
Animal tumor inhibition tests show that this product has inhibitory effects on mouse sarcoma S180, cervical cancer U14, Lewis lung cancer and melanoma. In vitro tests show that this product has a certain direct inhibitory effect on human gastric cancer FGC85, liver cancer SMMC7721, leukemia K562 and HL60 cell lines. This product does not inhibit the immune function of tumor-bearing rats. When used in combination with Western anticancer agents (chemotherapy), it can also improve immunosuppression and leukopenia.
Ingredients
Curcuma zedoaria, Trillium gracile, Brucea javanica, Strychnos nux vomica powder, beehive, etc.
Appearance
This product is a hard capsule, the contents of which are brown granules and powder; it has a unique aroma and tastes bitter and slightly spicy.
Usage and Dosage
Oral administration. 5 capsules at a time, 4 times a day, one month as a course of treatment, or follow the doctor's advice.
Adverse Reactions
Occasionally, nausea may occur after taking the medicine.
Precautions
It is forbidden for pregnant women to use.
Special Population Medication
Precautions for children: There is no research data on the safety and effectiveness of this product in children. Precautions for the elderly: Reduce the dosage or follow the doctor's advice.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
seal.
Packaging Specification
0.27g per tablet
Validity Period
30 months
Manufacturer
Beijing Boran Pharmaceutical Co., Ltd.
-
Founded in:
1982-02-02 -
Address:
Room 2102, Building B, No. 9 Chaoqian Road, Science and Technology Park, Changping District, Beijing -
Tax NO.:
911101147214449202 -
Registered Funds:
6.3 million yuan -
Website:
-
Email: